These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6487486)

  • 41. Urea kinetics evaluation of hemodialysis and CAPD patients.
    Acchiardo SR; Kraus AP; LaHatte G; Kaufman PA; Adkins D; Moore LW
    Adv Perit Dial; 1992; 8():55-8. PubMed ID: 1361852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peritoneal membrane characteristics in patients on peritoneal dialysis.
    Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of peritoneal dialysis method on residual renal function in children.
    Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Procainamide pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Raehl CL; Moorthy AV; Beirne GJ
    Nephron; 1986; 44(3):191-4. PubMed ID: 2431330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary experience with continuous ambulatory peritoneal dialysis.
    Rahman M; Haq SA; Haq A
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
    Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
    Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of chronic peritoneal dialysis on thyroid function tests.
    Robey C; Shreedhar K; Batuman V
    Am J Kidney Dis; 1989 Feb; 13(2):99-103. PubMed ID: 2916576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis.
    Chan MK; Browning AK; Poole CJ; Matheson LA; Li CS; Baillod RA; Moorhead JF
    Nephron; 1985; 41(2):161-5. PubMed ID: 4047273
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of mycophenolate mofetil in patients with end-stage renal failure.
    MacPhee IA; Spreafico S; Bewick M; Davis C; Eastwood JB; Johnston A; Lee T; Holt DW
    Kidney Int; 2000 Mar; 57(3):1164-8. PubMed ID: 10720968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 51. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis.
    Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C
    Nephron; 1984; 36(2):111-3. PubMed ID: 6607420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of continuous ambulatory peritoneal dialysis (CAPD) in patients of chronic renal failure.
    Banerjee S; Ratnu KS
    J Assoc Physicians India; 1984 Jun; 32(6):495-8. PubMed ID: 6511726
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetics of cefotaxime in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis.
    Hasegawa H; Imada A; Horiuchi A; Nishii Y; Fukushima M; Kurokawa E
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():135-42. PubMed ID: 6094432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Peritoneal Protein Losses Depend on More Than Just Peritoneal Dialysis Modality and Peritoneal Membrane Transporter Status.
    Yoowannakul S; Harris LS; Davenport A
    Ther Apher Dial; 2018 Apr; 22(2):171-177. PubMed ID: 29314721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of lamivudine in subjects receiving peritoneal dialysis in end-stage renal failure.
    Asari A; Iles-Smith H; Chen YC; Naderer OJ; Johnson MA; Yuen GJ; Otto V; Dunn JA; Gokal R
    Br J Clin Pharmacol; 2007 Dec; 64(6):738-44. PubMed ID: 17662093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum and dialyzate concentrations of intraperitoneal cephalothin in patients undergoing continuous ambulatory peritoneal dialysis.
    Münch R; Steurer J; Lüthy R; Siegenthaler W; Kuhlmann U
    Clin Nephrol; 1983 Jul; 20(1):40-3. PubMed ID: 6883818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of increasing exchange volume and frequency on peritoneal dialysis adequacy.
    Gao H; Lew SQ; Bosch JP
    Clin Nephrol; 1998 Dec; 50(6):375-80. PubMed ID: 9877111
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD; Moore HL; Prowant B; Twardowski ZJ; Khanna R; Gamboa S; Keshaviah P
    ASAIO J; 1993; 39(3):M566-8. PubMed ID: 8268600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
    Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
    J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.